Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
Singh Chadha covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Insulet, and Edwards Lifesciences. According to TipRanks, Singh Chadha has an average return of 3.2% and a 54.38% success rate on recommended stocks.
In addition to RBC Capital, Globus Medical also received a Buy from Piper Sandler’s Matthew O’Brien in a report issued yesterday. However, on the same day, Stifel Nicolaus maintained a Hold rating on Globus Medical (NYSE: GMED).
Based on Globus Medical’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $769.05 million and a net profit of $118.97 million. In comparison, last year the company earned a revenue of $625.71 million and had a net profit of $51.84 million
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GMED in relation to earlier this year. Most recently, in November 2025, David Davidar, a Director at GMED sold 25,000.00 shares for a total of $2,150,000.00.
